Anthony Gregg Lapointe
CIK 1331860 · last filed 2026-10-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RIGL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
GAITHERSBURG, MD 20883-3216
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNGX | Director | — | $0.35 | — | $0 | 6 | 2026-10-13 |
| RIGL | Director | 18,250 | $49.91 | $910.9K | $0 | 10 | 2026-05-19 |
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 6 | 2026-01-23 |
| SOLIGENIX, INC. (SNGXW) Delisted | Director | — | $0.01 | — | $0 | 5 | 2021-09-24 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 5 | 2021-06-02 |
| SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Director | — | — | — | $0 | 10 | 2017-10-16 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | — | — | — | $0 | 1 | 2017-05-24 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 0 | — | — | $0 | 4 | 2016-10-26 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Director | — | — | — | $0 | 2 | 2016-06-21 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | — | — | — | $0 | 2 | 2010-01-04 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | — | — | — | $0 | 1 | 2007-01-04 |
Recent Filings · Page 4 of 7
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-11-02 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2017-10-16 | SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Disp (D) | — | $0 | EDGAR |
| 2017-06-12 | SOLIGENIX, INC. (SNGXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-09 | SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-24 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-26 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | −10,422 | -$93.8K | EDGAR |
| 2016-06-27 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | +8,330 | $0 | EDGAR |
| 2016-06-21 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-20 | — | Grant (A) | — | $0 | |
| 2016-06-13 | SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.